← Back to Research Library

Valence Labs Research

IGF-1 LR3

IGF Receptor Research Peptide

Compound
IGF-1 LR3
Category
Research Peptide
Available Variant
1mg
Research Status
Research Use Only

Overview

IGF-1 LR3, also described as Long R3 IGF-I, is an analogue of insulin-like growth factor I studied in IGF receptor signaling research.

Relative to native IGF-I, Long R3 IGF-I is examined for reduced interaction with IGF-binding proteins, supporting research on IGF/IGFBP relationships and cellular IGF signaling.

Research Areas

  • IGF Receptor Signaling

    IGF-1 LR3 is studied as an IGF-I analogue in research involving IGF receptor pathways.

  • IGF/IGFBP Interaction

    Research interest includes reduced interaction or affinity with IGF-binding proteins relative to native IGF-I.

  • Cellular Signaling

    Experimental work has used Long R3 IGF-I to examine cellular IGF signaling in laboratory models.

How It Is Being Studied

Research involving Long R3 IGF-I includes experimental and comparative models. Findings from those models should not be interpreted as established human treatment outcomes.

This page summarizes published research contexts and does not provide administration, dosing, or performance-related guidance.

Specifications

Catalog details for this product.

Product Name
IGF-1 LR3
Category
Research Peptide
Variant
1mg
Form
Documentation pending
Storage
Documentation pending
Purity
Documentation pending
Intended Use
Laboratory research use only

Available Documentation

Certificates of Analysis

IGF-1 LR3 1mg first-page preview
VerifiedFreedom Diagnostics

99.67%

Purity

Passed full QC panel

Variant
IGF-1 LR3 1mg
Lot
I0101
Net Peptide Content
1.51 mg
Endotoxin
Passed
Heavy Metals
Passed
Lab
Freedom Diagnostics

Available Product

IGF-1 LR3

1mg

View Product →